product summary
company name :
Cell Signaling Technology
product type :
antibody
product name :
YY1 (13G10) Rabbit mAb
catalog :
2185
clonality :
monoclonal
host :
rabbit
conjugate :
nonconjugated
clone name :
13G10
reactivity :
human, mouse, rat
application :
western blot, immunoprecipitation, blocking or activating experiments
citations: 20
Published Application/Species/Sample/DilutionReference
  • western blot; human; 1:1000; loading ...; fig 3c
LI Y, Du L, Aldana Masangkay G, Wang X, Urak R, Forman S, et al. Regulation of miR-34b/c-targeted gene expression program by SUMOylation. Nucleic Acids Res. 2018;: pubmed publisher
  • western blot; human; 1:1000; loading ...; fig 6c
Wang Y, Zhang J, Su Y, Shen Y, Jiang D, Hou Y, et al. G9a regulates breast cancer growth by modulating iron homeostasis through the repression of ferroxidase hephaestin. Nat Commun. 2017;8:274 pubmed publisher
  • blocking or activating experiments; human; loading ...; fig 4f
Deivendran S, Marzook H, Santhoshkumar T, Kumar R, Pillai M. Metastasis-associated protein 1 is an upstream regulator of DNMT3a and stimulator of insulin-growth factor binding protein-3 in breast cancer. Sci Rep. 2017;7:44225 pubmed publisher
  • western blot; human; fig 6
Navarro F, Lieberman J. miR-34 and p53: New Insights into a Complex Functional Relationship. PLoS ONE. 2015;10:e0132767 pubmed publisher
Moz S, Basso D, Bozzato D, Galozzi P, Navaglia F, Negm O, et al. SMAD4 loss enables EGF, TGFβ1 and S100A8/A9 induced activation of critical pathways to invasion in human pancreatic adenocarcinoma cells. Oncotarget. 2016;7:69927-69944 pubmed publisher
Merry C, McMahon S, Forrest M, Bartels C, Saiakhova A, Bartel C, et al. Transcriptome-wide identification of mRNAs and lincRNAs associated with trastuzumab-resistance in HER2-positive breast cancer. Oncotarget. 2016;7:53230-53244 pubmed publisher
Chen C, Wei X, Lv Z, Sun X, Wang S, Zhang Y, et al. Cyclic Equibiaxial Tensile Strain Alters Gene Expression of Chondrocytes via Histone Deacetylase 4 Shuttling. PLoS ONE. 2016;11:e0154951 pubmed publisher
Ochoa Cortes F, Turco F, Liñán Rico A, Soghomonyan S, Whitaker E, Wehner S, et al. Enteric Glial Cells: A New Frontier in Neurogastroenterology and Clinical Target for Inflammatory Bowel Diseases. Inflamm Bowel Dis. 2016;22:433-49 pubmed publisher
Katunga L, Gudimella P, Efird J, Abernathy S, Mattox T, Beatty C, et al. Obesity in a model of gpx4 haploinsufficiency uncovers a causal role for lipid-derived aldehydes in human metabolic disease and cardiomyopathy. Mol Metab. 2015;4:493-506 pubmed publisher
Zani I, Stephen S, Mughal N, Russell D, Homer Vanniasinkam S, Wheatcroft S, et al. Scavenger receptor structure and function in health and disease. Cells. 2015;4:178-201 pubmed publisher
Zhang L, Ji Y, Jiang W, Lv C. Protective roles of pulmonary rehabilitation mixture in experimental pulmonary fibrosis in vitro and in vivo. Braz J Med Biol Res. 2015;48:545-52 pubmed publisher
Wang Z, Li H, Zhang D, Liu X, Zhao F, Pang X, et al. Effect of advanced glycosylation end products on apoptosis in human adipose tissue-derived stem cells in vitro. Cell Biosci. 2015;5:3 pubmed publisher
Lok K, Basta M, Manzanero S, Arumugam T. Intravenous immunoglobulin (IVIg) dampens neuronal toll-like receptor-mediated responses in ischemia. J Neuroinflammation. 2015;12:73 pubmed publisher
Yamagishi S, Fukami K, Matsui T. Crosstalk between advanced glycation end products (AGEs)-receptor RAGE axis and dipeptidyl peptidase-4-incretin system in diabetic vascular complications. Cardiovasc Diabetol. 2015;14:2 pubmed publisher
Wilkins H, Carl S, Greenlief A, Festoff B, Swerdlow R. Bioenergetic dysfunction and inflammation in Alzheimer's disease: a possible connection. Front Aging Neurosci. 2014;6:311 pubmed publisher
Szczepanski M, Luczak M, Olszewska E, Molińska Glura M, Zagor M, Krzeski A, et al. Molecular signaling of the HMGB1/RAGE axis contributes to cholesteatoma pathogenesis. J Mol Med (Berl). 2015;93:305-14 pubmed publisher
Wang W, Lu Q, Zhang J, Wang B, Liu X, An F, et al. HMGB1 mediates hyperglycaemia-induced cardiomyocyte apoptosis via ERK/Ets-1 signalling pathway. J Cell Mol Med. 2014;18:2311-20 pubmed publisher
Potluri V, Noothi S, Vallabhapurapu S, Yoon S, Driscoll J, Lawrie C, et al. Transcriptional repression of Bim by a novel YY1-RelA complex is essential for the survival and growth of Multiple Myeloma. PLoS ONE. 2013;8:e66121 pubmed publisher
Rudra D, deRoos P, Chaudhry A, Niec R, Arvey A, Samstein R, et al. Transcription factor Foxp3 and its protein partners form a complex regulatory network. Nat Immunol. 2012;13:1010-9 pubmed publisher
Yokoyama N, Pate K, Sprowl S, Waterman M. A role for YY1 in repression of dominant negative LEF-1 expression in colon cancer. Nucleic Acids Res. 2010;38:6375-88 pubmed publisher
product information
SKU :
2185S
Product-Name :
YY1 (13G10) Rabbit mAb
Size :
100 ul
Price-(USD) :
235 USD
Species-x-Reactivity :
H, M, R
Applications :
Immunoprecipitation
Product-Category :
Chromatin Regulation / Nuclear Function
Shipping-Temp :
AMBIENT
Storage-Temp :
-20°C
Product-Type :
Monoclonal Antibody
MW :
65
Host :
Rabbit
Target :
YY1
Primary-Protein :
YY1
Alt-Names :
DELTA,Delta transcription factor,INO80 complex subunit S,INO80S,NF-E1,TYY1,Transcriptional repressor protein YY1,UCRBP,YIN-YANG-1,YY-1,YY1,YY1 transcription factor,Yin and Yang 1 protein,Yin and yang 1,yin yang 1
company information
Cell Signaling Technology
3 Trask Lane
Danvers, MA 01923
info@cellsignal.com
https://www.cellsignal.com
8776162355
headquarters: USA
Established in Beverly, MA in 1999, Cell Signaling Technology (CST) is a privately-owned company with over 400 employees worldwide. We are dedicated to providing innovative research tools that are used to help define mechanisms underlying cell function and disease. Since its inception, CST has become the world leader in the production of the highest quality activation-state and total protein antibodies utilized to expand knowledge of cell signaling pathways. Our mission is to deliver the world's highest quality research tools that accelerate progress in biological research and personalized medicine.